Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Key highlights Retatrutide is a next-generation weight loss medication that activates GLP-1, GIP, and glucagon receptors simultaneously to promote appetite suppression, improve metabolic health, and increase energy expenditure
Liver Health & Metabolic Benefits Evidence suggests a reduced risk of hepatic failure and inflammation
The American Diabetes Association (ADA) guidelines recommend GLP-1 receptor agonists as preferred agents for patients with type 2 diabetes who have established atherosclerotic cardiovascular disease or indicators of high cardiovascular risk, or for those requiring additional glucose-lowering beyond metformin
Patients should seek medical advice if they experience symptoms of thyroid dysfunction despite treatment, or if they develop concerning symptoms such as difficulty swallowing, voice changes, or a rapidly enlarging neck mass
If cloudiness or particulate matter persists, do not use the solution
US$ 20.44
US$ 22.57
US$ 23.41
US$ 29.30
